Course Provider
Learning Objectives
Participants will discuss the new and emerging systemic therapy options for muscle-invasive bladder cancer and how they can be effectively integrated into clinical practice.
Participants will describe recent updates to the systemic therapy options for locally advanced/metastatic urothelial cancer as well as the patient and disease characteristics that may guide treatment choice.
Participants will review the results of recent clinical trials involving the systemic treatment of bladder cancer and their potential impact on management of bladder cancer.